** Shares of metabolic health solutions firm ReShape Lifesciences RSLS.O fall 57.5% to $1 premarket
** On Saturday, RSLS said it is raising $6 mln through a public offering of shares and warrants
** Co selling ~2.6 mln units, each consisting of one share and one warrant, at $2.33 per unit
** Warrants can be exercised at a price of $5.83 per share, after stockholder approval
** Maxim Group LLC is acting as the sole agent for the offering
** RSLS fell ~71% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.